Burkina Faso vs Dominican Republic: Access to anti-retroviral drugs, male
Burkina Faso
68.0%
in 2024
Dominican Republic
68.0%
in 2024
Burkina Faso rank
73rd
Dominican Republic rank
73rd
Access to anti-retroviral drugs, male over time
- Burkina Faso
- Dominican Republic
How they compare
Burkina Faso currently reports 68.0% against 68.0% in Dominican Republic, a difference of 0.0%.
The two have swapped places 4 times across 25 shared years of data; in 2000 it was Dominican Republic ahead.
Burkina Faso ranks 73rd and Dominican Republic ranks 73rd of 141 countries.
Burkina Faso has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Burkina Faso | Dominican Republic | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 9.1% | 4.5% | 4.6% | Burkina Faso |
| 2010s | 40.3% | 30.8% | 9.5% | Burkina Faso |
| 2020s | 60.8% | 59.2% | 1.6% | Burkina Faso |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Burkina Faso or Dominican Republic?
- Burkina Faso, at 68.0% against 68.0% in Dominican Republic as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Burkina Faso and Dominican Republic?
- 0.0%, with Burkina Faso ahead.
- How many years of comparable data are there for Burkina Faso and Dominican Republic?
- 25 years are reported by both, from 2000 to 2024.
- How do Burkina Faso and Dominican Republic rank globally for access to anti-retroviral drugs, male?
- Burkina Faso ranks 73rd and Dominican Republic ranks 73rd of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.